GLP-1 receptor agonists, such as semaglutide (sold under the brand name Ozempic or Wegovy) and tirzepatide (brand name Mounjaro or Zepbound), are medications originally developed for diabetes and now approved for chronic weight management at specific doses
Add your clinical experience in the comments for community discussion
[3] The topical wound-healing question is currently under formal investigation
Buyer Takeaway: When comparing GLP-1 telehealth platforms, the most meaningful differentiators are transparency markers - named clinical entity, named pharmacy with verifiable license, explicit compounding disclosure, all-in pricing, and complete published refund terms
PlexusDx patients have direct access to clinical support to distinguish medication effects from thyroid-related concerns
If you have any concerns or would like to book a consultation, please dont hesitate to contact us